Surgery News and Research

RSS

Minority patients and those of lower socioeconomic status are more likely to have advanced thyroid cancer

UCLA researchers have found that minority patients and those of lower socioeconomic status are far more likely to have advanced thyroid cancer when they are diagnosed with the disease than white patients and those in higher economic brackets.

10 Jan 2014

Undergraduate students develop innovative, non-X-ray device that evaluates spinal movement

Those have undergone extensive back surgery and need repeated X-rays to monitor their progress may soon have access to a new technology that skips the X-rays and repeated radiation exposure, opting instead for an innovative, noninvasive, non-X-ray device that evaluates spinal movement.

10 Jan 2014

T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke, heart attack victims

T2 Biosystems, a company developing direct detection products enabling superior diagnostics, announced that scientists from the University of Pennsylvania and T2 Biosystems have published a paper in Blood describing novel clot structure biology detected while testing T2 Bio's T2HemoStat-.

10 Jan 2014

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Gastric bypass surgery is a type of bariatric operation that results in weight loss and stimulates metabolic effects that treat diabetes and other cardiovascular risk factors such as diabetes, high cholesterol, and hypertension.

9 Jan 2014

Bio-inspired biodegradable surgical glue repairs defects of heart and blood vessels

Gecko Biomedical, a French medical device company developing 'bio-inspired' biodegradable surgical glues and patches for wound closure, announces that the Company's co-founders have published data demonstrating the potential of its paradigm-shifting technologies for minimally invasive reconstructive heart surgery.

9 Jan 2014

Subset of TH17 cells linked to inflammation in Crohn’s disease patients, find TSRI scientists

Two-thirds to three-quarters of the estimated 700,000 Americans living with Crohn’s disease, an autoimmune condition that can disrupt the entire gastrointestinal tract, will require surgery at some point during their life. Patients and physicians often turn to this surgical intervention after a patient develops resistance to current treatments, such as steroids.

9 Jan 2014

Auxilium Pharmaceuticals reports interim data from XIAFLEX Phase 4 study in patients with DC

Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.

9 Jan 2014

Immune tolerance to grafts of muscle, bone and skin could free recipients from lifelong immunosuppression

Massachusetts General Hospital investigators have made an important step towards greater availability of hand transplants, face transplants and other transplants involving multiple types of tissue.

9 Jan 2014

TSRI scientists identify small subset of immune cells that play major role in development of Crohn's disease

Two-thirds to three-quarters of the estimated 700,000 Americans living with Crohn's disease, an autoimmune condition that can disrupt the entire gastrointestinal tract, will require surgery at some point during their life.

9 Jan 2014

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.

9 Jan 2014

Viewpoints: Health law debate on contraceptive coverage; Cuccinelli: No investigators for Medicaid fraud; 50 years after the famed report on smoking

The Little Sisters of the Poor, an organization of Roman Catholic nuns that runs nursing homes around the country, is testing the contraceptive coverage mandate of the Affordable Care Act. Last week, we're sorry to say, the nuns won a temporary reprieve from Supreme Court Justice Sonia Sotomayor. Under the law, most employers are required to provide their employees with health insurance that covers birth control. But the Obama administration agreed to a compromise for nonprofit religious groups that object to contraception, exempting them from paying for such coverage. Instead, insurers agreed to absorb the cost. All the religious organization has to do is fill out a simple form attesting to its situation. Unfortunately, even that was too much for the Little Sisters of the Poor (1/7).

9 Jan 2014

Globus Medical acquires Excelsius Surgical

Globus Medical, Inc., a leading musculoskeletal implant manufacturer, today announced that it has acquired Excelsius Surgical. Excelsius Surgical is developing a next generation surgical robotic positioning platform for spine, brain and therapeutic markets.

9 Jan 2014

Mild electronic stimulation therapy to upper airway during sleep effective in reducing OSA

Results published in a new study in the Jan. 9 issue of the New England Journal of Medicine report that mild electronic stimulation therapy to the upper airway during sleep is effective in reducing obstructive sleep apnea (OSA).

9 Jan 2014

Teleflex includes Vidacare vascular products in ARROW Vascular Access family

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, will be showcasing ARROW Vascular Products along with the newly acquired Vidacare vascular product line at the annual Society of Critical Care Medicine, January 9-13 in San Francisco, California.

9 Jan 2014

Montreal researchers identifies two specific key players in growth of GBM

Glioblastoma (GBM) is the most common and deadly form of primary malignant brain cancer accounting for approximately 15% of all brain tumours and occurring mostly in adults between the ages of 45 and 70.

9 Jan 2014

Bio-inspired adhesive may help surgeons treat congenital heart defects, other heart problems

When a child is born with a heart defect such as a hole in the heart, the highly invasive therapies are challenging due to an inability to quickly and safely secure devices inside the heart.

9 Jan 2014

Cosmetic results after "lumpectomy" differ for African-American versus Caucasian women

As perceived by both patients and doctors, the cosmetic results after "lumpectomy" for breast cancer differ for African-American versus Caucasian women, suggests a pilot study in the Plastic and Reconstructive Surgery-Global Open-, the official open-access medical journal of the American Society of Plastic Surgeons (ASPS).

9 Jan 2014

Implantation of sleep apnea device can lead to improvements for patients with OSA

Implantation of a sleep apnea device called Inspire- Upper Airway Stimulation therapy can lead to significant improvements for patients with obstructive sleep apnea, according to a study published today in the New England Journal of Medicine.

9 Jan 2014

Poor people more likely to become frail after a heart attack

As people get older, their bodies wear down and become less resilient. In old age, it's common for people to become "clinically frail," and this "frailty syndrome" is emerging in the field of public health as a powerful predictor of healthcare use and death.

9 Jan 2014

Carl Zeiss Meditec acquires 100% of shares in Aaren Scientific

Carl Zeiss Meditec AG announces it has acquired, through its subsidiary Carl Zeiss Meditec Inc., 100% of the shares in Aaren Scientific Inc., a US-based manufacturer of intraocular lenses (IOLs). Aaren Scientific, headquartered in Ontario, California, has been manufacturing IOLs for more than two decades. The majority of shares in Aaren Scientific had previously been owned by a private investment company as well as other investors, including the CEO and co-founder of Aaren Scientific, Rick Aguilera, who along with the entire management team will stay on board after the transaction.

8 Jan 2014

Surgery News and Research

Minority patients and those of lower socioeconomic status are more likely to have advanced thyroid cancer

Undergraduate students develop innovative, non-X-ray device that evaluates spinal movement

T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke, heart attack victims

Gastric bypass and cardiovascular disease risk: an interview with Dr. Brethauer, Cleveland Clinic

Bio-inspired biodegradable surgical glue repairs defects of heart and blood vessels

Subset of TH17 cells linked to inflammation in Crohn’s disease patients, find TSRI scientists

Auxilium Pharmaceuticals reports interim data from XIAFLEX Phase 4 study in patients with DC

Immune tolerance to grafts of muscle, bone and skin could free recipients from lifelong immunosuppression

TSRI scientists identify small subset of immune cells that play major role in development of Crohn's disease

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

Viewpoints: Health law debate on contraceptive coverage; Cuccinelli: No investigators for Medicaid fraud; 50 years after the famed report on smoking

Globus Medical acquires Excelsius Surgical

Mild electronic stimulation therapy to upper airway during sleep effective in reducing OSA

Teleflex includes Vidacare vascular products in ARROW Vascular Access family

Montreal researchers identifies two specific key players in growth of GBM

Bio-inspired adhesive may help surgeons treat congenital heart defects, other heart problems

Cosmetic results after "lumpectomy" differ for African-American versus Caucasian women

Implantation of sleep apnea device can lead to improvements for patients with OSA

Poor people more likely to become frail after a heart attack

Carl Zeiss Meditec acquires 100% of shares in Aaren Scientific

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News